Optimized strategy of switching to tenofovir alafenamide fumarate treatment for nucleos(t)ide analogue experienced patients with chronic hepatitis B.

Front Med (Lausanne) · 2025 · PMC12660252 · PMID 41322205

Europe PMC DOI

hedged sentence

0.0130

closest p · 0.3× alpha

0.0130

boldest claim

The sentences

a decreasing trendp = 0.013actually significant

Serological response In all enrolled patients, HBeAg showed a decreasing trend at 24 ± 2w and 48 ± 2w ( χ 2 = 8.715, p = 0.013) compared with baseline.

also in 27,535 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.